About Ekso Bionics (NASDAQ:EKSO)
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness. The company's Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California. Ekso Bionics Holdings, Inc. operates as a subsidiary of Magee Rehabilitation Hospital.
Industry, Sector and Symbol
Industry General industrial machinery,
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:EKSO
CUSIPN/A
Phone510-984-1761
Debt
Debt-to-Equity Ratio0.23%
Current Ratio3.81%
Quick Ratio3.48%
Price-To-Earnings
Trailing P/E Ratio-1.81
Forward P/E Ratio-3.36
P/E GrowthN/A
Sales & Book Value
Annual Sales$7.35 million
Price / Sales13.23
Cash FlowN/A
Price / CashN/A
Book Value$0.36 per share
Price / Book4.49
Profitability
EPS (Most Recent Fiscal Year)($0.89)
Net Income$-29,120,000.00
Net Margins-396.04%
Return on Equity-246.15%
Return on Assets-107.72%
Miscellaneous
Employees92
Outstanding Shares60,220,000
Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions
What is Ekso Bionics' stock symbol?
Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."
When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work?
Shares of Ekso Bionics reverse split before market open on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split.
How were Ekso Bionics' earnings last quarter?
Ekso Bionics (NASDAQ:EKSO) announced its quarterly earnings data on Tuesday, March, 13th. The company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by $0.05. The company had revenue of $2.45 million for the quarter. Ekso Bionics had a negative return on equity of 246.15% and a negative net margin of 396.04%. View Ekso Bionics' Earnings History.
When is Ekso Bionics' next earnings date?
What price target have analysts set for EKSO?
1 analysts have issued 12 month price targets for Ekso Bionics' stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate Ekso Bionics' stock price to reach $4.00 in the next twelve months. View Analyst Ratings for Ekso Bionics.
Who are some of Ekso Bionics' key competitors?
Some companies that are related to Ekso Bionics include Xoma (XOMA), Miragen Therapeutics (MGEN), Teligent (TLGT), Summit Therapeutics (SMMT), Spero Therapeutics (SPRO), Zafgen (ZFGN), Nabriva Therapeutics (NBRV), Protagonist Therapeutics (PTGX), Kamada (KMDA), Spring Bank Pharmaceuticals (SBPH), Foamix Pharmaceuticals (FOMX), Avid Bioservices (CDMO), Immune Design (IMDZ), Proteostasis Therapeutics (PTI), Immupharma (IMM), Helius Medical Technologies (HSDT), Intec Pharma (NTEC) and XBiotech (XBIT).
Who are Ekso Bionics' key executives?
Ekso Bionics' management team includes the folowing people:
- Mr. Jack Peurach, Pres, CEO & Director (Age 52)
- Mr. Maximilian Scheder-Bieschin, Chief Financial Officer (Age 56)
- Mr. Russell L. DeLonzor, Chief Operating Officer (Age 56)
- Mr. Gregory Davault, Chief Marketing Officer (Age 50)
- Mr. Ruediger Hausherr, Pres of Europe
Has Ekso Bionics been receiving favorable news coverage?
Media headlines about EKSO stock have been trending somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies negative and positive press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Ekso Bionics earned a daily sentiment score of 0.11 on Accern's scale. They also gave media headlines about the company an impact score of 45.09 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Ekso Bionics?
Shares of EKSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ekso Bionics' stock price today?
One share of EKSO stock can currently be purchased for approximately $1.6150.
How big of a company is Ekso Bionics?
Ekso Bionics has a market capitalization of $98.15 million and generates $7.35 million in revenue each year. The company earns $-29,120,000.00 in net income (profit) each year or ($0.89) on an earnings per share basis. Ekso Bionics employs 92 workers across the globe.
How can I contact Ekso Bionics?
Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at 510-984-1761 or via email at [email protected]
MarketBeat Community Rating for Ekso Bionics (EKSO)
MarketBeat's community ratings are surveys of what our community members think about Ekso Bionics and other stocks. Vote "Outperform" if you believe EKSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EKSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
Ekso Bionics (NASDAQ:EKSO) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Ekso Bionics in the last 12 months. Their average twelve-month price target is $4.00, suggesting that the stock has a possible upside of 147.68%. The high price target for EKSO is $4.00 and the low price target for EKSO is $4.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $4.00 | $4.00 | $4.00 | $4.00 |
| Price Target Upside: | 147.68% upside | 145.40% upside | 145.40% upside | 145.40% upside |
Ekso Bionics (NASDAQ:EKSO) Consensus Price Target History
Ekso Bionics (NASDAQ:EKSO) Analyst Ratings History
Show:
(Data available from 4/21/2016 forward)
Ekso Bionics (NASDAQ:EKSO) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Ekso Bionics (NASDAQ EKSO) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.32%
Institutional Ownership Percentage: 38.69%
Ekso Bionics (NASDAQ EKSO) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/22/2017 | Russ Angold | Insider | Sell | 50,000 | $3.51 | $175,500.00 | |  |
| 9/14/2017 | Amy Mcbride Wendell | Director | Buy | 16,264 | $1.23 | $20,004.72 | 16,264 | |
| 9/8/2017 | Thomas Looby | CEO | Buy | 15,000 | $1.13 | $16,950.00 | 20,315 | |
| 9/7/2017 | Max Scheder-Bieschin | CFO | Buy | 10,000 | $1.13 | $11,300.00 | 32,371 | |
| 8/23/2017 | Russ Angold | Insider | Sell | 9,352 | $1.33 | $12,438.16 | 241,326 | |
| 8/16/2017 | Russ Angold | Insider | Sell | 28,254 | $1.53 | $43,228.62 | 250,678 | |
| 8/15/2017 | Russ Angold | Insider | Sell | 221,746 | $1.55 | $343,706.30 | 400,678 | |
| 11/11/2016 | Max Scheder-Bieschin | CFO | Buy | 1,000 | $4.00 | $4,000.00 | 9,817 | |
(Data available from 1/1/2013 forward)
Ekso Bionics (NASDAQ EKSO) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | These bionic vests give factory workers super strength and help prevent injuries
finance.yahoo.com - April 20 at 5:30 PM |
 | Analysts Set Expectations for Ekso Bionics Holdings, Inc.'s Q1 2019 Earnings (EKSO)
www.americanbankingnews.com - April 16 at 2:44 AM |
| -$0.07 Earnings Per Share Expected for Ekso Bionics Holdings, Inc. (EKSO) This Quarter
www.americanbankingnews.com - April 13 at 11:17 PM |
| Nordson (NDSN) and Ekso Bionics (EKSO) Financial Contrast
www.americanbankingnews.com - April 10 at 3:22 PM |
| Ekso Bionics (EKSO) versus Altra Industrial Motion (AIMC) Head to Head Survey
www.americanbankingnews.com - April 10 at 5:30 AM |
| Ekso Bionics (EKSO) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - April 9 at 11:27 PM |
| Contrasting Altra Industrial Motion (AIMC) & Ekso Bionics (EKSO)
www.americanbankingnews.com - April 8 at 11:21 PM |
| Ekso Bionics (EKSO) & Nordson (NDSN) Head to Head Comparison
www.americanbankingnews.com - April 8 at 9:32 PM |
 | Medical Bionics Market is Forecasted to Generate a Revenue of $28.1 Billion By 2023: P&S Market Research
globenewswire.com - April 5 at 9:56 AM |
| Head-To-Head Contrast: Ekso Bionics (EKSO) vs. Altra Industrial Motion (AIMC)
www.americanbankingnews.com - April 4 at 7:07 AM |
| Ekso Bionics (EKSO) versus Nordson (NDSN) Head-To-Head Review
www.americanbankingnews.com - April 4 at 7:07 AM |
| When Should You Buy Ekso Bionics Holdings Inc (NASDAQ:EKSO)?
finance.yahoo.com - March 30 at 8:09 AM |
| Medical Bionics Market is Expected to Reach US$ 36,818.2 Million By 2026: Credence Research
globenewswire.com - March 28 at 8:15 AM |
 | EKSO Leaps, FDA Nod For DRIO, CRVS Up 38% This Month, VTL To Report Data In Sep.
www.finanznachrichten.de - March 27 at 8:15 AM |
 | Pre-Market Technical Scan on Medical Supplies Equities -- Becton, Dickinson and Co., Ekso Bionics, Cooper, and Waters - PR Newswire (press release)
www.prnewswire.com - March 19 at 8:10 AM |
| Edited Transcript of EKSO earnings conference call or presentation 13-Mar-18 8:30pm GMT
finance.yahoo.com - March 18 at 8:08 AM |
| Ekso Bionics Reports Fourth Quarter and Year End 2017 Results - GlobeNewswire (press release)
www.globenewswire.com - March 14 at 8:15 AM |
 | Ekso Bionics' (EKSO) CEO Jack Peurach on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 14 at 8:15 AM |
 | Robbins Arroyo LLP: Ekso Bionics Holdings, Inc. (EKSO) Misled ... - Business Wire (press release)
www.businesswire.com - March 14 at 8:15 AM |
| Ekso Bionics Reports Fourth Quarter and Year End 2017 Results ... - GlobeNewswire (press release)
globenewswire.com - March 14 at 8:15 AM |
| Ekso Bionics Reports Fourth Quarter and Year End 2017 Results
finance.yahoo.com - March 13 at 7:26 PM |
| Was Ekso Bionics Holdings Inc’s (NASDAQ:EKSO) Earnings Growth Better Than The Industry’s?
finance.yahoo.com - March 13 at 8:12 AM |
| Ekso Bionics Announces Executive Leadership Changes; Jack Peurach, co-founder of Ekso Bionics, long-time board ... - GlobeNewswire (press release)
globenewswire.com - March 12 at 6:48 PM |
 | Ekso Bionics (EKSO) Names Jack Peurach as President and CEO ... - StreetInsider.com
www.streetinsider.com - March 12 at 6:48 PM |
| Ekso Bionics® to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018
finance.yahoo.com - March 6 at 5:47 PM |
| Ekso Bionics® to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 - GlobeNewswire (press release)
globenewswire.com - March 6 at 8:06 AM |
| MARCH 5 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm
finance.yahoo.com - February 28 at 6:10 PM |
| DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm
finance.yahoo.com - February 28 at 8:06 AM |
| FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) To Contact The Firm
finance.yahoo.com - February 27 at 6:02 PM |
| DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. And Reminds Investors With Losses In Excess of $50,000 To Contact The Firm
finance.yahoo.com - February 26 at 5:51 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSO
finance.yahoo.com - February 24 at 8:05 AM |
| PLG Reminds Ekso Bionics Holdings, Inc. Investors of Important March 5, 2018 Lead Plaintiff Deadline in Class Action - EKSO
finance.yahoo.com - February 23 at 6:06 PM |
| Zacks: Brokerages Anticipate Ekso Bionics Holdings, Inc. (EKSO) to Post -$0.10 EPS
www.americanbankingnews.com - February 22 at 1:10 AM |
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018
finance.yahoo.com - February 14 at 3:40 PM |
 | BRIEF-Ekso Bionics To Expand Clinical Trial Sites For Comparative Multicenter WISE Study
www.reuters.com - February 12 at 3:38 PM |
| EKSO INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors
finance.yahoo.com - February 12 at 3:38 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSO
finance.yahoo.com - February 10 at 8:43 AM |
| Ekso Bionics Holdings, Inc. Reminder: Important March 5, 2018 Lead Plaintiff Deadline in Class Action - EKSO
finance.yahoo.com - February 8 at 3:36 PM |
| Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO) - Business Wire (press release)
www.businesswire.com - February 8 at 8:05 AM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018
finance.yahoo.com - February 8 at 8:05 AM |
| IMPORTANT EKSO BIONICS HOLDINGS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who suffered losses in Ekso Bionics Holdings, Inc.
finance.yahoo.com - February 8 at 8:05 AM |
| INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.
finance.yahoo.com - February 8 at 8:05 AM |
| Report: Exploring Fundamental Drivers Behind Dow Chemical, Bank Of New York Mellon, New York Community, Frontier Communications, TAL Education Group, and Ekso Bionics — New Horizons, Emerging Trends, and Upcoming Developments
finance.yahoo.com - February 7 at 8:23 AM |
| Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO)
finance.yahoo.com - February 6 at 3:36 PM |
| DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ekso Bionics Holdings, Inc. to Contact the Firm
finance.yahoo.com - February 6 at 8:25 AM |
| IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.
finance.yahoo.com - February 5 at 3:35 PM |
| Ekso Bionics Holdings, Inc. (EKSO) Expected to Post Earnings of -$0.10 Per Share
www.americanbankingnews.com - February 5 at 1:10 AM |
 | EKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors
www.bizjournals.com - February 1 at 3:36 PM |
| EKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors
finance.yahoo.com - February 1 at 3:36 PM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018
finance.yahoo.com - February 1 at 3:36 PM |
Ekso Bionics (NASDAQ:EKSO) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Ekso Bionics (NASDAQ EKSO) Stock Chart for Saturday, April, 21, 2018
Loading chart…
